Immunobiology
The CD28 molecule is a disulfide-linked homodimer expressed on the surface of T cells and it binds to the natural ligand B7 family members, CD80/CD86, expressed on antigen-presenting cells, resulting in costimulation of T cell activation. 1 In humans, all thymocytes and the vast majority of peripheral blood T cells express CD28 at birth. An increase of the proportion of CD8 + T cells lacking CD28 expression has been demonstrated in the aged population, 2 HIV-infected individuals 3, 4 and bone marrow transplant recipients. 5, 6 In contrast, in healthy individuals, only a few percent of CD4 + T cells lack CD28, 3 and expansion of CD4 + CD28 − T cells is scarcely reported in rheumatoid arthritis patients. Loss of CD28 expression has recently been implicated in lymphocyte senescence. 9, 10 We have previously reported the oligoclonal expansions of CD8 +
CD28
− T lymphocytes in recipients of allogeneic bone marrow grafts and the demonstration of identical T cell clones within both CD8 +
− and CD8 + CD28 + T cell subsets. 11 These results suggest that clonally expanded CD8 + CD28 − T cells after allogeneic hematopoietic cell transplantation (HCT) are derived from the CD8 + CD28 + T cell subset, presumably by an antigen-driven mechanism. In the present study, we have addressed the question of whether clonal expansion of CD4 +
− T cells is also observed in recipients of allogeneic hematopoietic cell grafts and whether these cells are the descendents of CD4 + T cells expressing CD28.
Materials and methods

Patients
Informed consent was obtained from the patients before blood samples were collected. All the patients were conditioned with myeloablative chemoradiotherapy, mostly consisting of fractionated total body irradiation (12 Gy in six fractions) and cyclophosphamide (60 mg/kg/day for 2 days), followed by infusion of allogeneic marrow or blood stem cell grafts from HLA-matched donors. All the patients received cyclosporin A and short-term methotrexate for prophylaxis of acute graft-versus-host disease (GVHD).
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Engraftment was achieved in all patients, and confirmed by recovery of hematopoiesis and the presence of donorderived sex chromosomes or mismatched antigens on red cells. All patients were seropositive for cytomegalovirus (CMV). Patients were monitored for CMV infection by weekly CMV antigenemia assays from when the granulocyte count reached 500/l until day 100 after transplantation. Patients who were positive for CMV antigenemia assay received prophylactic ganciclovir (5 mg/kg/day, 3 days a week) from the time the granulocyte count became greater than 1000/l. 
TCRBV repertoire analysis
Analysis of the T cell receptor ␤-chain variable region (TCRBV) repertoire was performed by an adapter ligation PCR-based microplate hybridization assay, as reported previously. 13, 14 Briefly, total RNA was extracted from PBMCs and converted to double-strand cDNA using a SuperScript cDNA synthesis kit (BRL, Bethesda, MD, USA). The P10EA/P20EA adapters were ligated to the 5′ end of cDNA prepared from PBMCs, and PCR was performed using a biotinylated TCRCB-specific primer and a P20EA primer. Biotinylated PCR products were hybridized with immobilized TCRBV-specific primers in 96-well microtiter plates. Subsequently, alkaline phosphatase-conjugated streptavidin was added to each well and a colorimetric assay was performed. Skewing of the TCR repertoire was defined as a significant increase of TCRBV subfamilies to a greater percentage than the mean plus three standard deviations (s.d.) of 20 healthy individuals, and exceeded 5% of total circulating blood T cells. 14 
PCR amplification and CDR3 size distribution analysis of the TCR-␤ chain
The procedure for CDR3 size analysis (spectratyping) for the TCR-␤ chain has been described elsewhere. 15, 16 Total RNA was extracted from PBMCs using an RNeasy Total RNA Kit (Qiagen; Hilden, Germany) and was used for firststrand cDNA synthesis with an oligo-dT primer (FirstStrand cDNA Synthesis Kit; Amersham Pharmacia Biotech, Uppsala, Sweden). Aliquots of the cDNA were amplified with a V␤-specific primer and a C␤-specific primer. Primer sequences were described previously. 16, 17 PCR amplification was performed for 40 cycles in a 20 l reaction mixture containing 0.2 m of each primer and 0.5 U of Taq polymerase (TaKaRa, Osaka, Japan). Conditions for the PCR were as follows: denaturation at 94°f or 1 min, annealing at 55°C for 1 min, and extension at 72°f or 1.5 min. Following the 40 cycles of PCR, an additional extension at 72°C for 15 min was performed. The PCR buffer was 10 mm Tris-HCl (pH 8.3), 50 mm KCl, 1.5 mm MgCl 2 , and 0.2 mm of each dNTP.
Aliquots (4 l) of the unlabeled V␤-C␤ PCR products were subjected to one cycle of elongation (runoff reaction) with a FAM-labeled nested C␤ primer (FAM-CB3) under the following conditions: denaturation at 94°for 2 min, annealing at 55°for 1 min, and extension at 72°for 15 min. The reaction buffer was the same as that described above. The labeled PCR products were mixed with the size marker (GeneScan-500 TAMRA; Applied Biosystems, Warrington, UK), and loaded on to a 5% polyacrylamide sequencing gel for determination of size and fluorescence intensity using an automated DNA sequencer (ABI 377; Perkin-Elmer Applied Biosystems, Foster, CA, USA). Data were analyzed using GeneScan software (Perkin-Elmer Applied Biosystems).
Sequencing of CDR3 region in the TCR-␤ chain
PCR products of the TCR-␤ chain were cloned into the PCR2.1 TA cloning vector (Invitrogen, Carlsbad, CA, USA) and sequenced using a Big-Dye Terminator Cycle Sequencing Kit (Perkin-Elmer Applied Biosystems). 18 Sequence analysis was performed using an Applied Biosystems 377A automatic DNA sequencer.
Results
Oligoclonal expansion of CD4 + CD28 -T cells after allogeneic hematopoietic cell transplantation
We have previously reported the oligoclonal expansion of CD8 + T cells lacking CD28 expression during an early period after allogeneic bone marrow transplantation, which imposes skewing upon the post-transplant TCR repertoire of circulating blood T cells. 11 + T lymphocytes in 23 patients who received allogeneic bone marrow grafts. There was a marked increase of the CD28 − T cell fraction in CD4 + T cells during an early period after transplantation (Figure 1) .
We then examined the TCRBV repertoire of the CD4 + CD28 − T cell subset using FACS-sorted cells from three selected patients, and identified TCRBV subfamilies predominantly used by those cells (Table 1) . Clonalities of CD4 + CD28 − T cells carrying the skewed TCRBV subfamilies were determined by CDR3 size spectratyping, and they were compared to those of CD4 + CD28 + T cells (Figure 2 ). The CD4
+ CD28 − T cell subset showed less diversity than CD4 + CD28 + T cells. Thus, oligoclonal expansion was evident in the CD4 + CD28 − T cell subset after allogeneic hematopoietic cell transplantation (HCT). Months post transplant CD4+CD28-/CD4+ total
Identification of the same clones within both CD4
Figure 1 Expansion of the CD28
− subset in CD4 + T cells after allogeneic bone marrow transplantation. Data from 23 patients receiving allogeneic marrow grafts are graphically presented. A regression curve using a threedimensional polynomial equation was added. The shaded area shows the mean ± one standard deviation of the data from eleven healthy individuals.
identify T cells with the same CDR3 sequences within both subsets. We subcloned PCR products of skewed TCR-␤ chains to see if identical CDR3 sequences could be found in both CD4 +
CD28
− and CD4 + CD28 + subsets. We found identical sequences in both subsets in all three patients examined ( Table 2) .
Discussion
We have demonstrated the clonal expansion of CD4 + CD28 − T lymphocytes after human allogeneic HCT and the presence of identical clonal T cells within both CD4 + CD28 + and CD4 + CD28 − T cell subsets. These results suggest that both subsets are phenotypic variants of the same lineage. It remains uncertain whether the transition between the two subsets is unidirectional or bi-directional, although the transition between the CD8 + CD28 + and the CD8 + CD28 − T cell subsets appears to be unidirectional. CD8
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CD28
− T cells is observed during the early period after allogeneic marrow transplantation, and that there are T cell clones with identical CDR3 sequences within both CD8 +
− and CD8 + CD28 + T cell subsets. 11 Loss of CD28 expression appears to be associated with clonal predominance of T lymphocytes after allogeneic HCT. Clonal expansion is one of the principal features of T cell immune responses against antigens, 24, 25 and there is accumulating evidence for an association between the loss of CD28 expression and T lymphocyte aging.
9,10 CD8 + CD28 − T cells have recently been considered to be the terminally differentiated effector cells in a state of replicative senescence. 6, 9 Accumulation of CD4 + CD28 − T cells following allogeneic HCT may be explained by several mechanisms. Like CD8 +
T lymphocytes, CD4
+ T cells may be chronically stimulated by certain antigens present in the host and then downregulate the CD28 expression during clonal expansion. 21 
Alternatively, CD4
+ CD28 − T cells may be resistant to cell death and have a slow turnover. There is evidence for clonal expansion of CD4 + CD28 − T cells in rheumatoid arthritis patients, and resistance to apoptosis and elevated expression of Bcl-2 are responsible for clonal expansion of CD4 + CD28 − T cells. 7, 8, 26 The antigen specificity and functional properties of clonally expanded CD4 + CD28 − T cells found in recipients of allogeneic hematopoietic stem cell grafts are largely unknown. However, there are some clues that allow us to speculate about their specificity and functions. Hooper et al 27 have reported that expansion of CD4 + CD28 − CD57 + T cells in rheumatoid arthritis patients are found only in cytomegalovirus (CMV) seropositive donors. The CD8 + CD28
− T cell population has been shown to contain virus-specific memory cytotoxic T lymphocytes that respond to human CMV and human immunodeficiency virus (HIV). [28] [29] [30] [31] [32] It is well known that reactivation of CMV occurs during the first 3 months after allogeneic marrow transplantation and there is a report describing the association between expansion of CD8 + T cells and CMV infection. 33 Thus, clonally expanded CD4 + CD28 − T cells produced following allogeneic HCT may be derived from T cells recognizing antigens that persistently exist in the host such as herpesviruses. This issue can be addressed using major histocompatibility complex (MHC)-peptide tetramers for dominant viral epitopes.
34-36
Identical T cell clones in CD4
+ CD28 + and CD4 + CD28 − subsets M Hirokawa et al 1099 Table 2 Deduced amino acid sequences of CDR3 regions of the TCR-␤ chain in CD4 
